These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 4341746)

  • 1. Angiotensin II antagonism. Structure-activity relationships of 8-substituted angiotensin II analogs.
    Fessler DC; Slipos F; Denning GS; Pals DT; Masucci FD
    J Med Chem; 1972 Oct; 15(10):1015-6. PubMed ID: 4341746
    [No Abstract]   [Full Text] [Related]  

  • 2. Synthesis of some analogs of angiotensin II as specific antagonists of the parent hormone.
    Khosla MC; Leese RA; Maloy WL; Ferreira AT; Smeby RR; Bumpus FM
    J Med Chem; 1972 Aug; 15(8):792-5. PubMed ID: 4339769
    [No Abstract]   [Full Text] [Related]  

  • 3. Solid-phase synthesis of (3-proline,8-isoleucine)-,(1-sarcosine,3-proline,8-isoleucine)-, and (4-phenylalanine,8-isoleucine)angiotensin II as the antagonists of the parent hormone.
    Khosla MC; Hall MM; Smeby RR; Bumpus FM
    J Med Chem; 1973 Oct; 16(10):1184-5. PubMed ID: 4356140
    [No Abstract]   [Full Text] [Related]  

  • 4. Agonist and antagonist relationships in 1- and 8-substituted analogs of angiotensin II.
    Khosla MC; Hall MM; Smeby RR; Bumpus FM
    J Med Chem; 1974 Nov; 17(11):1156-60. PubMed ID: 4369767
    [No Abstract]   [Full Text] [Related]  

  • 5. Factors that influence the antagonistic properties of angiotensin II antagonists.
    Khosla MC; Hall MM; Smeby RR; Bumpus FM
    J Med Chem; 1973 Jul; 16(7):829-32. PubMed ID: 4353602
    [No Abstract]   [Full Text] [Related]  

  • 6. Angiotensin-like and antagonistic activities of N-terminal modified (8-leucine)angiotensin II peptides.
    Paiva TB; Goissis G; Juliano L; Miyamoto ME; Paiva AC
    J Med Chem; 1974 Feb; 17(2):239-41. PubMed ID: 4358432
    [No Abstract]   [Full Text] [Related]  

  • 7. Synthesis of analogs of (8-isoleucine)angiotensin II with variations in position 1.
    Khosla MC; Hall MM; Smeby RR; Bumpus FM
    J Med Chem; 1974 Apr; 17(4):431-3. PubMed ID: 4364509
    [No Abstract]   [Full Text] [Related]  

  • 8. Alkylating analogs of peptide hormones. 2. Synthesis and properties of p-(N,N-bis(2-chloroethyl)amino)phenylbutyryl derivatives of angiotensin II.
    Paiva TB; Paiva AC; Freer RJ; Stewart JM
    J Med Chem; 1972 Jan; 15(1):6-8. PubMed ID: 4331919
    [No Abstract]   [Full Text] [Related]  

  • 9. New specific angiotensin antagonists. (8-Valine)-, (8-isoleucine)-, and chlorambucil-des-1-aspartic,8-valine-angiotensins I.
    Paiva AC; Nouaihetas VL; Miyamoto ME; Mendes GB; Paiva TB
    J Med Chem; 1973 Jan; 16(1):6-9. PubMed ID: 4344926
    [No Abstract]   [Full Text] [Related]  

  • 10. Solid-phase synthesis of (6-arginine)-, (4-histidine, 6-tyrosine)-, and (8-isoleucine)angiotensins II.
    Khosla MC; Kumar S; Smeby RR; Bumpus FM
    J Med Chem; 1972 Jun; 15(6):627-9. PubMed ID: 4337901
    [No Abstract]   [Full Text] [Related]  

  • 11. Angiotensin analogs: the influence of sarcosine substituted in position 1.
    Hall MM; Khosla MC; Khairallah PA; Bumpus FM
    J Pharmacol Exp Ther; 1974 Jan; 188(1):222-8. PubMed ID: 4358436
    [No Abstract]   [Full Text] [Related]  

  • 12. Angiotensin II. Synthesis and biological activity of 6-(1-methylhistidine) and 6-(3-methylhistidine) analogs.
    Needleman P; Marshall GR; Rivier J
    J Med Chem; 1973 Sep; 16(9):968-70. PubMed ID: 4355510
    [No Abstract]   [Full Text] [Related]  

  • 13. Synthesis of angiotensin II antagonists containing N- and O-methylated and other amino acid residues.
    Khosla MC; Mũnoz-Ramírez H; Hall MM; Smeby RR; Khairallah PA; Bumpus FM; Peach MJ
    J Med Chem; 1976 Feb; 19(2):244-50. PubMed ID: 2777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacology of antagonists of angiotensin I and II.
    Needleman P; Johnson EM; Vine W; Flanigan E; Marshall GR
    Circ Res; 1972 Dec; 31(6):862-7. PubMed ID: 4345101
    [No Abstract]   [Full Text] [Related]  

  • 15. Angiotensin II analogs. 11. Further studies on des-aspartyl-angiotensin II.
    Jorgensen EC; Kiraly-Olah IC; Lee TC; Windridge GC
    J Med Chem; 1974 Mar; 17(3):323-6. PubMed ID: 4359545
    [No Abstract]   [Full Text] [Related]  

  • 16. Synthesis of angiotensin II antagonists by incorporating alpha-methylalanine or O-methylthreonine residues in angiotension II analogues.
    Khosla MC; Muñoz-Ramírez H; Hall MM; Khairallah PA; Bumpus FM
    J Med Chem; 1977 Aug; 20(8):1051-5. PubMed ID: 894674
    [No Abstract]   [Full Text] [Related]  

  • 17. Characterization of smooth muscle receptors for angiotensin: studies with an antagonist.
    Mimran A; Hinrichs KJ; Hollenberg NK
    Am J Physiol; 1974 Jan; 226(1):185-90. PubMed ID: 4358849
    [No Abstract]   [Full Text] [Related]  

  • 18. A potent competitive antagonist of angiotensin II.
    Yamamoto M; Türker RK; Khairallah PA; Bumpus FM
    Eur J Pharmacol; 1972 May; 18(3):316-22. PubMed ID: 4338477
    [No Abstract]   [Full Text] [Related]  

  • 19. Biologically active derivatives of angiotensin for labeling cellular receptors.
    Galardy RE; Stafford SS; Schaefer ML; Ho H; La Vorgna KA; Jamieson JD
    J Med Chem; 1978 Dec; 21(12):1279-83. PubMed ID: 214560
    [No Abstract]   [Full Text] [Related]  

  • 20. Study on the influence of tyrosine deprotonation on the myotropic action of angiotensin II.
    Escher E; Guillemette G
    Can J Physiol Pharmacol; 1979 Mar; 57(3):317-20. PubMed ID: 36212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.